Published in Drug Week, May 2nd, 2003
The data were presented at the 50th annual scientific meeting of the Society for Gynecologic Investigation in Washington, DC.
Phenoxodiol is an experimental anticancer drug manufactured by Novogen, Ltd. and is being brought to market by its Marshall Edwards, Inc. (MEI) subsidiary. MEI was established to provide a commercial vehicle for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.